Healio

FDA grants premarket approval to supersaturated oxygen therapy for STEMI

Please provide your email address to receive an email when new articles are posted on . TherOx Inc. announced that a therapy to reduce heart tissue damage in patients with left anterior descending ...
Monthly Prescribing Reference

White Blood Cell Count Predicts Infarct Size in STEMI

Unrecognized MI Prevalent in Older Adults, Ups Mortality For patients with anterior wall ST-segment elevated myocardial infarction (STEMI), elevated white blood cell count (WBCc) on presentation is ...
Medscape

FDA Approves Supersaturated-Oxygen Device as Addition to PCI for LAD-STEMI

A system that allows intracoronary delivery of blood "supersaturated" with oxygen after coronary stenting has received market approval from the US Food and Drug Administration (FDA), the developer, ...
Nature

Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction

ST-segment elevation myocardial infarction (STEMI) is associated with high morbidity and mortality, but timely reperfusion is known to result in dramatically improved patient outcomes. As many as 40% ...